<DOC>
	<DOCNO>NCT02638376</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy KXL system vibeX Rapid ( Riboflavin Ophthalmic Solution ) Corneal Collagen Cross-Linking eye : 1 . Keratoconus ( KC ) , 2 . Post LASIK ectasia ( PLEc )</brief_summary>
	<brief_title>Evaluating Safety Efficacy KXL System Corneal Collagen Cross-Linking Eyes Having Keratoconus</brief_title>
	<detailed_description>KC Plec eye Group 1 ( non-randomised control ) Eyes assign 2 group : - Treatment eye group KXL - Control eye group ( fellow eye ) The Treatment eye cross link KXL system vibeX Rapid Riboflavin , control eye receive treatment . The safety efficacy endpoint evaluate compare Treatment eye group Control eye group . After 6 month follow KC PLEc subject offer treat control eye indicate . Group 2 ( non-randomised control combined treatment ) Eyes assign 2 group : - Treatment group simultaneous KXL topography-guided transepithelial photorefractive keratectomy ( PRK ) - Control eye group ( fellow eye ) The Treatment eye undergo simultaneous topography-guided PRK cross link KXL system vibeX Rapid Riboflavin , control eye receive treatment . The safety efficacy endpoint evaluate compare Treatment eye group Control eye group . After 6 month follow KC PLEc subject offer treat control eye indicate . The concentration Riboflavin Ophthalmic Solution test - 0.1 % Riboflavin ophthalmic solution KC Eyes irradiate 30mW/cm2 4 minute continuous treatment 8 minute pulse treatment : 1 second 1 second . PLEc Eyes irradiate 30mW/cm2 4 minute continuous treatment 8 minute pulse treatment : 1 second 1 second off..</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Age Limit keratoconus Plec:18 year 2 . Sign inform consent . 3 . Willingness ability follow instruction comply schedule followup visit ; 4 . Contact Lens Wearers Only : Minimum 3 day 5 . For KC subject : 1 . Axial topography consistent keratoconus ( Pentacam ) 2 . Presence central inferior steepen Pentacam map ; 3 . Steepest keratometry ( Kmax ) value â‰¥ 47.00 D ; 4 . May corneal scar include CLEK grade 4.0 ( scar dense/opaque stromal scar consistent KC ) 5 . Keratoconus progress time ( evidence topography change , visual acuity refractive change ) 6 . For PLEc subject : 1 . Having diagnosis corneal ectasia corneal refractive surgery ( e.g. , LASIK , PRK , epiLASIK , LASEK , ) 2 . Presence central inferior steepen Pentacam map . 3 . Axial topography consistent corneal ectasia 1 . Contraindications , sensitivity know allergy use test article ( ) component ; 2 . If female , pregnant , nurse plan pregnancy positive urine pregnancy test Visit 2 prior randomization course study ; 3 . For KC PLEc subject , corneal pachymetry &lt; 400microns prior epithelial debridement thin point measure Pentacam eye treat ; 4 . A history chemical injury delay epithelial healing eye ( ) treat ; 5 . Patients nystagmus condition would prevent steady gaze treatment diagnostic test ; 6 . Patients current condition , investigator 's opinion , would interfere prolong epithelial healing ; 7 . Taking Vitamin C ( ascorbic acid ) supplement within 1 week crosslinking treatment , retinoic acid within 6 month treatment 8 . Previous ocular condition ( refractive error ) eye treat may predispose eye future complication . For example : 8.1 . History corneal disease ( e.g. , herpes simplex , herpes zoster keratitis , recurrent erosion syndrome , corneal melt , corneal dystrophy , etc . ) ; 8.2 . Clinically significant corneal scar crosslinking treatment zone investigator 's opinion , interfere crosslinking procedure ; 9 . For KC subject 9.1 . Eyes aphakic ; 9.2 . Eyes maximum corneal curvature ( Kmax ) , identify measure Pentacam , outside central 5mm zone ; Note : In addition , Investigator may exclude discontinue subject sound medical reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Keraroconus</keyword>
	<keyword>keratectasia</keyword>
	<keyword>treatment</keyword>
</DOC>